{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:39:34Z","timestamp":1791243574668,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,20]],"date-time":"2018-05-20T00:00:00Z","timestamp":1526774400000},"content-version":"vor","delay-in-days":139,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G090132"],"award-info":[{"award-number":["G090132"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000304","name":"Parkinson's UK","doi-asserted-by":"publisher","award":["J-1204"],"award-info":[{"award-number":["J-1204"]}],"id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.nicl.2018.05.027","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T13:53:05Z","timestamp":1527169985000},"page":"683-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Parkinson's disease related signal change in the nigrosomes 1\u20135 and the substantia nigra using T2* weighted 7T MRI"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9019-4755","authenticated-orcid":false,"given":"Stefan Theodor","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Mougin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Blazejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nin","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee P.","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Gowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2018.05.027_bb0005","first-page":"245","article-title":"A cognitive bedside assessment beyond the MMSE: the Addenbrooke's cognitive examination","volume":"7","author":"Bak","year":"2007","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.nicl.2018.05.027_bb0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1212\/WNL.0b013e31829e6fd2","article-title":"Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI","volume":"81","author":"Blazejewska","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2018.05.027_bb0015","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.parkreldis.2013.08.011","article-title":"Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease","volume":"19","author":"Bunzeck","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nicl.2018.05.027_bb0020","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1148\/radiol.14131448","article-title":"MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease","volume":"271","author":"Cosottini","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.nicl.2018.05.027_bb0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3174\/ajnr.A4158","article-title":"Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease","volume":"36","author":"Cosottini","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"Pt 8","key":"10.1016\/j.nicl.2018.05.027_bb0030","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/brain\/122.8.1421","article-title":"The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry","volume":"122","author":"Damier","year":"1999","journal-title":"Brain J. Neurol."},{"issue":"Pt 8","key":"10.1016\/j.nicl.2018.05.027_bb0035","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.nicl.2018.05.027_bb0040","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nicl.2018.05.027_bb0045","series-title":"Recent developments in Parkinson's disease","article-title":"Fahn S, Elton RI, and members of the UPDRS Development Committee. The unified Parkinson's disease rating scale","author":"Fahn","year":"1987"},{"issue":"Pt 5","key":"10.1016\/j.nicl.2018.05.027_bb0050","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.nicl.2018.05.027_bb0055","first-page":"174","article-title":"T2-imaging changes in the nigrosome-1 relate to clinical measures of Parkinson's disease","volume":"7","author":"Fu","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nicl.2018.05.027_bb0060","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.canep.2013.08.002","article-title":"Median percent change: a robust alternative for assessing temporal trends","volume":"37","author":"Geraci","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.nicl.2018.05.027_bb0065","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.45.6.1138","article-title":"Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease","volume":"45","author":"Gorell","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2018.05.027_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nicl.2018.05.027_bb0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jmri.22752","article-title":"High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease","volume":"35","author":"Lotfipour","year":"2012","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2018.05.027_bb0080","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/mds.26932","article-title":"Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson\u2019s disease","volume":"32","author":"Mahlknecht","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nicl.2018.05.027_bb0085","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","article-title":"Midbrain iron content in early Parkinson disease - a potential biomarker of disease status","volume":"70","author":"Martin","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2018.05.027_bb0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/ene.13208","article-title":"Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility","volume":"24","author":"Martin-Bastida","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nicl.2018.05.027_bb0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nicl.2016.11.015","article-title":"9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease","volume":"13","author":"Massey","year":"2016","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.nicl.2018.05.027_bb0100","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3174\/ajnr.A4412","article-title":"Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality","volume":"36","author":"Noh","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2018.05.027_bb0105","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/mds.26171","article-title":"Dorsolateral nigral hyperintensity on 3.0\u202fT susceptibility-weighted imaging in neurodegenerative Parkinsonism","volume":"30","author":"Reiter","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.nicl.2018.05.027_bb0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nicl.2013.10.006","article-title":"Diffusion tensor imaging of nigral degeneration in Parkinson's disease: a region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis","volume":"3","author":"Schwarz","year":"2013","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.nicl.2018.05.027_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093814","article-title":"The \u2018swallow tail\u2019 appearance of the healthy nigrosome \u2013 a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3\u202fT","volume":"9","author":"Schwarz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nicl.2018.05.027_bb0120","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1148\/radiol.2016160662","article-title":"In vivo assessment of brainstem depigmentation in parkinson disease: potential as a severity marker for multicenter studies","volume":"283","author":"Schwarz","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.nicl.2018.05.027_bb0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01244786","article-title":"Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain","volume":"74","author":"Sofic","year":"1988","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nicl.2018.05.027_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057904","article-title":"Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up","volume":"8","author":"Ulla","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nicl.2018.05.027_bb0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/jmri.21563","article-title":"MRI assessment of basal ganglia iron deposition in Parkinson's disease","volume":"28","author":"Wallis","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2018.05.027_bb0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.parkreldis.2014.11.017","article-title":"Longitudinal midbrain changes in early Parkinson's disease: iron content estimated from R2*\/MRI","volume":"21","author":"Wieler","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nicl.2018.05.027_bb0145","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1212\/WNL.58.12.1815","article-title":"Progression of gait disorder and rigidity and risk of death in older persons","volume":"58","author":"Wilson","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2018.05.027_bb0150","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.67.7_suppl_2.S8","article-title":"A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease","volume":"67","author":"Zecca","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2018.05.027_bb0155","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2008.05541.x","article-title":"Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease","volume":"106","author":"Zecca","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nicl.2018.05.027_bb0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2010.03.036","article-title":"Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study","volume":"1330","author":"Zhang","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.nicl.2018.05.027_bb0165","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00702-006-0453-2","article-title":"2006. Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability","volume":"113","author":"Zucca","year":"1996","journal-title":"J. Neural Transm. Vienna Austria"}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158218301736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158218301736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:18:04Z","timestamp":1761970684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158218301736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":33,"alternative-id":["S2213158218301736"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2018.05.027","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson's disease related signal change in the nigrosomes 1\u20135 and the substantia nigra using T2* weighted 7T MRI","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2018.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}